Skip to content

Studying the Effect of prolotherapy in diabetic foot ulcer

Comparing the effect of Prolotherapy with Placebo, in patients with diabetic foot ulcer

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20220424054636N1
Enrollment
60
Registered
2022-05-17
Start date
2022-05-14
Completion date
Unknown
Last updated
2022-05-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic foot ulcer. Diabetes mellitus due to underlying condition

Interventions

Intervention 1: Intervention group: injection of 1ml dextrose 10% per each cm2 of wound up to 10ml, 3 times per week, in the base and periphery of wound. Intervention 2: Control group: injection of 1m

Sponsors

Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Age > 18 years old Patients with confirmed type 1 or 2 diabetes mellitus HbA1C = 7-10% Ability to understand and collaborate during the study Having at least one chronic ulcer lasting for more than 4 weeks Plantar or dorsal or malleolar ulceration ABI = 0.7 - 1.2 in ischemic ulcers Ulcers with Wagner grades 2, 3 Ulcers with wound area = 1-20 cm2 None of the patients had received glucocorticoid, estrogen, or other drugs that interfere healing process within the past 1 month Patients who signed the informed consent

Exclusion criteria

Exclusion criteria: Patients with a history of malignancy or coagulopathy GFR < 30 ml/min/1.73m2 Albumin level < 3.5 g/dl Pregnancy

Design outcomes

Primary

MeasureTime frame
Wound area. Timepoint: Before intervention and 7, 14, 21 and 28 days after intervention. Method of measurement: Digital imaging to measure wound area.;Patient's pain scale. Timepoint: Before intervention and 7, 14, 21 and 28 days after intervention. Method of measurement: Visual Analogue Scale.

Secondary

MeasureTime frame
White blood cell. Timepoint: Before and after intervention. Method of measurement: Complete blood cells test.;Erythrocyte sedimentation rate. Timepoint: Before and after intervention. Method of measurement: Quantitative measurement of erythrocyte sedimentation rate in blood.;C-reactive protein. Timepoint: Before and after intervention. Method of measurement: Quantitative measurement of C-reactive protein in blood.;Blood glucose. Timepoint: Before and after intervention. Method of measurement: Glucometry.;Ankle - Brachial index. Timepoint: Before and after intervention. Method of measurement: Doppler sonography.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAsma Mafhoumi

Tehran University of Medical Sciences

asmamafhoumi@yahoo.com+98 21 6601 9264

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026